InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“CBN”), will be a featured company in the upcoming Cannabis Industry Virtual Investor Conference, slated for Sept. 8–9, 2021; INM’s presentation is scheduled for Sept. 8 at 1:30 p.m. ET. The two-day conference is an exclusive opportunity for cannabis company leaders to share the vision and mission of their companies and meet with potential investors.The conference is hosted by Virtual Investor Conferences (“VIC”) in partnership with KCSA Strategic Communications. VIC is part of OTC Market Group’s suite of investor relations services and is designed to be an interactive forum for publicly traded companies to meet and present directly with investors. The event replicates the look and feel of onsite investor conferences and combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network. “Our 15th virtual conference with the OTC Markets has generated significant interest from both investors and cannabis companies to where we again have extended the conference to two days,” said KCSA Strategic Communications managing director Phil Carlson in the press release. “We look forward to having some of the prominent global players in the cannabis industry present their story to the investment community.”
To register for the event, visit https://ibn.fm/0HHBZ
To view the full press release, visit https://ibn.fm/kjLyf
About InMed Pharmaceuticals Inc.
InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (“CBN”), in diseases with high unmet medical need. The company is dedicated to delivering new therapeutic alternatives to patients who may benefit from cannabinoid-based medicines. For more information, please visit www.InMedPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
